Search clinical trials for: RECELL® Autologous Cell Harvesting Device

Total 1013 results

N.N. Petrov National Medical Research Center of...

Unknown

Autologous Dendritic Cell Vaccine in Patients With Soft Tissue Sarcoma (ADCVCTAST)

Sarcoma | Neoplasms, Connective and Soft Tissue

Russian Federation
University of California, San Diego

Completed

mDiet - Ecological Momentary Intervention of Diet Via Mobile Technology

Overweight

United States
Indonesia University

Recruiting

Potential Use of Autologous and Allogeneic Mesenchymal Stem Cells in Patients With Multiple System Atrophy

Parkinsonism | Multiple System Atrophy | Multiple System Atrophy, Parkinson Variant

Indonesia
Tianjin Medical University General Hospital

Not yet recruiting

Autologous Hematopoietic Stem Cell Transplantation for Refractory Multiple Sclerosis

Multiple Sclerosis
Uppsala University
Karolinska University Hospital; Sahlgrenska University Hospital, Sweden; University... and other collaborators

Completed

Hematopoietic Stem Cell Transplantation for Treatment of Multiple Sclerosis in Sweden (AutoMS-Swe)

Multiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting

Sweden
Mayo Clinic
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Recurrent Glioblastoma

Recurrent Glioblastoma | Giant Cell Glioblastoma | Recurrent Gliosarcoma

United States
Red de Terapia Celular
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia and other collaborators

Completed

Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis Pigmentosa (TC/RP)

Retinitis Pigmentosa

Spain
Vinmec Research Institute of Stem Cell and Gene...

Completed

Outcomes of Expanded Autologous Bone Marrow-derived Mesenchymal Stem Cells Therapy in Type II Diabetes (ASD2)

Type 2 Diabetes Mellitus

Vietnam
Radboud University Medical Center

Completed

Single-step Antigen Loading and TLR Activation of Dendritic Cells in Melanoma Patients

Melanoma

Netherlands
Meir Medical Center

Unknown

Iron and Vitamin Adminstration Prior to Joint Replacement to Prevent Transfusion

Excessive Amount of Blood / Fluid Transfusion

Israel
BlueRock Therapeutics
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Phase 1 Safety and Tolerability Study of MSK-DA01 Cell Therapy for Advanced Parkinson's Disease

Advanced Parkinson's Disease

United States, Canada
Assistance Publique - Hôpitaux de Paris

Completed

"WB-DCE-MRI" in Multiple Myeloma as an Independent Prognostic Factor for Disease-free Survival (EVALICEMM)

Multiple Myeloma

France
Cairo University

Unknown

The Use of Autologous Bone Marrow Mesenchymal Stem Cells in the Treatment of Articular Cartilage Defects

Degenerative Arthritis | Chondral Defects | Osteochondral Defects

Egypt
University Medical Center Groningen

Terminated

Cell Savers and Blood Quality

Coronary Artery Bypass, Off-Pump

Netherlands
Dipenkumar Modi
Genmab

Recruiting

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

Relapsed Cancer | Refractory Cancer | Large Cell Lymphoma, Diffuse

United States
Fuling Zhou

Recruiting

Helical Tomotherapy in Multiple Myeloma

Multiple Myeloma

China
University Medical Centre Ljubljana
Stanford University; Blood Transfusion Centre of Slovenia

Completed

Safety and Efficacy Study of Stem Cell Transplantation to Treat Dilated Cardiomyopathy

Dilated Cardiomyopathy

Slovenia
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Completed

Adenovirus CCL-21 Transduced MART-1/gp100/Tyrosinase/NY-ESO-1 Peptide-Pulsed Dendritic Cells Matured

Melanoma (Skin)

United States
University of North Carolina, Chapel Hill
American Gastroenterological Association

Completed

Patient Acceptance and Preference Among Screening Modalities for Detection of Barrett's Esophagus

GERD | Barrett Esophagus

United States
Vinmec Research Institute of Stem Cell and Gene...

Recruiting

Adipose Tissue-derived Mesenchymal Stem Cell (AD-MSC) Therapy for the Treatment of Sexual Function Impairment in Female

Sexual Dysfunction Female

Vietnam
Stanford University

Completed

Sirolimus as Primary Therapy for the Treatment of Chronic Graft Versus Host Disease

Graft vs Host Disease | Blood and Marrow Transplant (BMT)

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer

Breast Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI); GlaxoSmithKline

Completed

Study of Melphalan and Topotecan (MT) Followed by Autologous Stem Cell Rescue in Patients With Multiple Myeloma.

Multiple Myeloma

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell Non-Hodgkin Lymphoma

Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Non-Hodgkin Lymphoma

United States
Ain Shams University

Completed

Lactoferrin Versus Iron Supplement in Irondeficiency Anemia and Weight Loss in Obese Children

Obesity, Childhood

Egypt
CSL Behring

Terminated

CSL200 Gene Therapy in Adults With Severe Sickle Cell Disease

Anemia, Sickle Cell

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma

Refractory Plasma Cell Myeloma | Plasmacytoma | Recurrent Plasma Cell Myeloma | Plasma Cell Leukemia

United States
Juan C. Ramos, MD

Withdrawn

Safety Trial of STING-dependent Activators and Stimulated Dendritic Cells for Aggressive Relapsed/Refractory Leukemias

Acute Lymphoblastic Leukemia | Acute Myelogenous Leukemia | Refractory Leukemia | Adult T-Cell Leukemia/Lymphoma | Relapsed Leukemia

United States
VA Office of Research and Development
National Cancer Institute (NCI); Jonsson Comprehensive Cancer Center

Terminated

A Vaccine Trial for Patients With Stage IIIB, IV, or Recurrent Non-Small Cell Lung Cancer (VTNSCLC)

Non-Small Cell Lung Cancer (NSCLC)

United States
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Terminated

Vaccine Therapy in Treating Patients With Acute Lymphoblastic Leukemia

Leukemia

United States
Opexa Therapeutics, Inc.

Terminated

Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis (OLTERMS)

Clinically Isolated Syndrome | Multiple Sclerosis, Relapsing-Remitting

United States
Chulalongkorn University

Unknown

Diagnostic Immunization With Rabies Vaccine in Patients With PID

Primary Immunodeficiency

Thailand
Mayo Clinic
National Cancer Institute (NCI)

Completed

Carfilzomib and Melphalan Before Stem Cell Transplant in Treating Patients With Multiple Myeloma

Refractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell Myeloma

United States
Zhi-Hong Liu, M.D.
Nanjing Medical University; Soochow University

Completed

Study of Bortezomib +HSCT in Primary Systemic Amyloidosis (AL)

Amyloidosis

China
Andalusian Initiative for Advanced Therapies -...
Iniciativa Andaluza en Terapias Avanzadas

Completed

Cell Infusion Intraportal Autologous Bone Marrow Mononuclear as Enhancer of Liver Regeneration

Liver Transplant Rejection

Spain
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Daratumumab After Stem Cell Transplant in Treating Patients With Multiple Myeloma

Plasma Cell Myeloma | Secondary Amyloidosis

United States
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...

Completed

Bioequivalence Study of Coated Cesol Tablet Formulation Versus Biltricide

Healthy

Germany
Sinovac Research and Development Co., Ltd.

Active, not recruiting

Effectiveness of Inactivated COVID-19 Vaccine of the First Booster Dose

COVID-19

Brazil
DynPort Vaccine Company LLC, A GDIT Company

Completed

Study of Reactogenicity, Safety, Immunogenicity, and Pock Lesion Formation of a Cell-Cultured Smallpox Vaccine Compared to Dryvax®

Smallpox

United States
University of Arkansas

Completed

UARK 89-001 Phase II Study of Intensive "TOTAL THERAPY" For Untreated or Minimally Treated Patients With Multiple Myeloma

Multiple Myeloma

United States
Qilu Hospital of Shandong University

Recruiting

Cardiac Toxicity and Prognostic Value of New Echocardiographic Indicators in the Treatment of Primary Multiple Myeloma

Multiple Myeloma

China
Pharmicell Co., Ltd.

Completed

REVIVE(Randomized Exploratory Clinical Trial to Evaluate the Safety and Effectiveness of Stem Cell Product in Alcoholic Liver Cirrhosis Patient)

Alcoholic Liver Cirrhosis

Korea, Republic of
Heinrich-Heine University, Duesseldorf
German Federal Ministry of Education and Research

Recruiting

Efficiency of Vaccination With Lysate-loaded Dendritic Cells in Patients With Newly Diagnosed Glioblastoma (GlioVax)

Glioblastoma

Germany
Mario Negri Institute for Pharmacological Research
Bio3 Research s.r.l. - Milan Italy

Completed

L-Cysteine in Peritoneal Dialysis (CINDY)

Uremia

Italy
American CryoStem Corporation

Not yet recruiting

Treatment of Long COVID Symptoms Utilizing Autologous Stem Cells Following COVID-19 Infection

Long COVID
Nanjing IASO Biotherapeutics Co.,Ltd

Not yet recruiting

A Phase 1/2 Study of CT120 in Patient With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

B-cell Non-Hodgkin's Lymphoma
Ottawa Hospital Research Institute
Multiple Sclerosis Scientific Research Foundation

Completed

Autologous Stem Cell Transplant for Multiple Sclerosis (MS/BMT)

Multiple Sclerosis

Canada
Northwestern University
University of Sao Paulo General Hospital

Withdrawn

Hematopoietic Stem Cell Support Versus Insulin in T1D

Diabetes Mellitus, Type 1
Wuerzburg University Hospital
Celgene Corporation; Amgen; ClinAssess GmbH; medac GmbH

Completed

Lenalidomide-Adriamycin-Dexamethasone (RAD) Induction Followed by Stem Cell Transplant in Newly Diagnosed Multiple Myeloma

Multiple Myeloma

Germany
National Heart, Lung, and Blood Institute (NHLBI)

Active, not recruiting

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat Dosing in Subjects With Stable Sickle Cell Disease: An Extension of a Phase I Pilot Study of Mitapivat

Sickle Cell Disease | Hemolytic Anemia

United States

Search clinical trials for: RECELL® Autologous Cell Harvesting Device

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations